Will taking 200mg of micronized progesterone from day 5 to day 28 of the menstrual cycle suppress ovulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Micronized Progesterone 200mg from Day 5-28 Will Suppress Ovulation

Yes, taking micronized progesterone 200mg daily from day 5 through day 28 of the menstrual cycle will suppress ovulation. This regimen provides continuous progesterone exposure during the follicular phase, which inhibits the midcycle gonadotropin surge necessary for ovulation.

Mechanism of Action

Progesterone plays a critical role in regulating the menstrual cycle and ovulation:

  • Progesterone administration during the follicular phase (when started on day 5) prevents the estrogen-primed LH surge that triggers ovulation 1
  • Continuous progesterone exposure disrupts the normal hypothalamic-pituitary-ovarian axis signaling required for follicular development and ovulation
  • The dose of 200mg is sufficient to achieve therapeutic serum levels that can alter endometrial development and hormonal feedback loops 2, 3

Evidence Supporting Ovulation Suppression

Research demonstrates that progesterone is essential for triggering the LH surge when present at the right time in the cycle, but continuous administration from early in the cycle prevents this process:

  • Studies using the antiprogesterone RU 486 showed that blocking progesterone action delayed the midcycle gonadotropin surge despite rising estradiol levels, confirming progesterone's critical role in ovulation timing 1
  • Seven days of continuous hormonal contraceptive use is deemed necessary to reliably prevent ovulation according to CDC guidelines 4
  • Starting progesterone on day 5 (early follicular phase) and continuing through day 28 provides more than the minimum duration needed for ovulation suppression

Dosage Considerations

The 200mg daily dose of micronized progesterone is clinically significant:

  • This dose is sufficient to produce adequate plasma and tissue levels of progesterone 2
  • It reproduces the anti-estrogenic effect of natural progesterone on the endometrium 2
  • Oral micronized progesterone at 200mg has been established as an effective dose for endometrial protection in hormone therapy regimens 3

Clinical Applications

This regimen is similar to approaches used in various clinical scenarios:

  • In hormone replacement therapy, 200mg of micronized progesterone is commonly used for 12-14 days per cycle or continuously 4
  • For contraception, continuous progestogen exposure is a key mechanism for preventing ovulation 4
  • In premature ovarian insufficiency management, similar progesterone dosing is used alongside estrogen therapy 4

Important Considerations

When using this regimen, be aware of:

  • Potential side effects including fluid retention, dizziness, and drowsiness 5
  • Micronized progesterone contains peanut oil and should not be used in patients with peanut allergies 5
  • Continuous progesterone administration may contribute to depressive symptoms in some women 6
  • Taking the dose at bedtime can minimize drowsiness side effects 3

This progesterone regimen starting on day 5 provides early and continuous exposure throughout the follicular phase, effectively preventing the hormonal cascade required for ovulation, making it an effective approach for ovulation suppression.

References

Research

Oral micronized progesterone.

Clinical therapeutics, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hormone Therapy Adjustments for Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.